Table 4.
The relative AUC(0–t) in rats after oral administration of CAT3 or SMEDDS.
Group | CAT3 in Plasma | Metabolite PF403 in Plasma | ||
---|---|---|---|---|
AUC(0–t) ng/L·h | Relative AUC(0–t)(%) | AUC(0-t) ng/L·h | Relative AUC(0–t)(%) | |
CAT3 | 5.911 ± 0.396 | 100.00 | 20.537 ± 0.256 | 100.00 |
SMEDDS | 10.564 ± 0.154 ** | 178.72 | 10.008 ± 0.677 ** | 48.73 |
CAT3 + Inhibition | 1.862 ± 0.356 ** | 31.50 | 5.747 ± 0.333 ** | 29.98 |
SMEDDS + Inhibition | 1.235 ± 0.166 ## | 11.69 Note 1 | 5.542 ± 0.455 ## Note 1 | 55.38 Note 1 |
** p < 0.01 vs. CAT3-API, ## p < 0.01 vs. CAT3-SMEDDS. Note 1: AUC (0–t) ng/L·h vs. SMEDDS.